Ann: Director Appointment/Resignation, page-9

First 9 Last

Share
Profile

Follow
Parma

2,826 Posts.

235

05/11/15

18:05

Post #: 16334380
Share

Originally posted by takeprofits ↑

Hi all, I have recently taken a position in COO during this SP weakness and management changes.

As has been stated before, both CEO's were on short term contracts and due to expire in December. Both had specific things to do. From the announcements, I take it that one has most likely failed, and the other has succeeded. They have resigned a couple of months before the end of the contracts, big deal.

From the latest announcement: "David Tonuri focused on driving changes to the business. This has created the necessary momentum for the company to strongly reassert itself within the pharmacy technology and ecommerce sectors."

Sounds positive to me. Lets now find a CEO for the long haul.

I put current share price weakness down to the fact no final dividend was paid and that impatient holders are selling out for that reason. After all, dividends are king at the moment. IMO, the previous dividend payout was unsustainable when the focus had shifted to 'growth'. I believe that, and would like to see dividends continued at either $0.0025 cents per half for a total of $0.005 cents per year, or one final dividend of $0.005 cents. Essentially, that is what management have implemented at full year, and if that continues, buying in today would give a yield around 4.5%.

With sticky revenue, a bulletproof balance sheet, positive cash flow and a war chest of cash, I see exciting times ahead.

Expand

Takeprofits,

Hopefully your tag name stays intact with your purchase of COO.
What really interests me is your reasoning for buying in, particularly as the share price weakened, key staff moving on, and nothing from management in terms of where to.

COO Price at posting: 10.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Trump is President Again: What Does This Mean for Crypto?

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

NHF

Burgeoning NZ insurance claims drive 1H25 operating loss for nib

ACW

Actinogen receives $9M R&D tax rebate to fund Alzheimer's trial

There are more pages in this discussion • 1 more message in this thread...

First 9 Last

Add PHX (ASX) to my watchlist

(20min delay)
Last 5.2¢		Change 0.005(10.6%)		Mkt cap ! $31.12M

Open	High	Low	Value	Volume
4.9¢	5.2¢	4.9¢	$36.99K	746.5K

Buyers (Bids)

No.	Vol.	Price($)
1	45976	5.0¢

Sellers (Offers)

Price($)	Vol.	No.
5.2¢	9999	1

View Market Depth

No.	Vol.	Price($)
1	45976	0.050
1	143911	0.049
1	200000	0.046
1	200000	0.043
1	132249	0.042

Price($)	Vol.	No.
0.052	9999	1
0.054	50000	1
0.055	725000	3
0.057	500000	1
0.060	17483	1

Last trade - 16.10pm 12/11/2024 (20 minute delay)

PHX (ASX) Chart

Ann: Director Appointment/Resignation, page-9

Trump is President Again: What Does This Mean for Crypto?

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Burgeoning NZ insurance claims drive 1H25 operating loss for nib

Actinogen receives $9M R&D tax rebate to fund Alzheimer's trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Director Appointment/Resignation, page-9

Top Stories

Trump is President Again: What Does This Mean for Crypto?

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Burgeoning NZ insurance claims drive 1H25 operating loss for nib

Actinogen receives $9M R&D tax rebate to fund Alzheimer's trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News